August 04, 2018
Article
An Extraordinary Healer essay honoring NIKI WOHLFORD-WILL, RN [LUTHERAN HEALTH NETWORK, FORT WAYNE, INDIANA]
October 01, 2017
FDA Approves Inlexzo for Some With Non–Muscle Invasive Bladder Cancer
Lunsumio plus Polivy Associated With Responses in MCL
Standing Up to Cancer with Lynch Syndrome
Zidesamtinib Elicits Responses in ROS1-Positive NSCLC